Arix Co-leads $50 Million Series B Financing for New Portfolio Company EvommuneLONDON, 27 April 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, announces that the Series B fi.